Microscale culture of human liver cells for drug development
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Tissue function depends on hierarchical structures extending from single cells ( approximately 10 microm) to functional subunits (100 microm-1 mm) that coordinate organ functions. Conventional cell culture disperses tissues into single cells while neglecting higher-order processes. The application of semiconductor-driven microtechnology in the biomedical arena now allows fabrication of microscale tissue subunits that may be functionally improved and have the advantages of miniaturization. Here we present a miniaturized, multiwell culture system for human liver cells with optimized microscale architecture that maintains phenotypic functions for several weeks. The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicity. We demonstrate utility through assessment of gene expression profiles, phase I/II metabolism, canalicular transport, secretion of liver-specific products and susceptibility to hepatotoxins. The combination of microtechnology and tissue engineering may enable development of integrated tissue models in the so-called 'human on a chip'.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, hepatic models that utilize conventional 2D mono-and co-cultures of normal and diseased human cells fail to mimic the complex threedimensional (3D) in vivo microenvironment and extracellular matrix (ECM) support [16,19,20].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [16]
In the citing paper
“The oxygenated or microfabricated co-cultures have been reported to allow HHs to retain metabolic function for a few weeks; however, these cells lose their proliferative capacity (Khetani and Bhatia, 2008; Kidambi et al., 2009”
From In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity (2018) · cites this paper as Khetani and Bhatia, 2008
Citations
Cites
Geometric Control of Cell Life and Death
Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M., & Ingber, D. E. (1997) · Science · doi:10.1126/science.276.5317.1425 · Cited by 4,657 · cited 1×
“Over the last decade, microtechnology tools have emerged to probe biomedical phenomena at relevant length scales and to miniaturize and parallelize biomedical assay”
BackgroundRheinwatd, J. G., & Green, H. (1975) · Cell · doi:10.1016/s0092-8674(75)80001-8 · Cited by 4,537
Soft Lithography in Biology and Biochemistry
Whitesides, G. M., Ostuni, E., Takayama, S., Jiang, X., & Ingber, D. E. (2001) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.3.1.335 · Cited by 2,607 · cited 1×
“Our approach incorporates 'soft lithography' techniques, using reusable, elastomeric molds of microfabricated structures to overcome limitations of photolithograph”
MethodIdiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054 · cited 1×
“The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicit”
BackgroundGenome-wide expression monitoring in Saccharomyces cerevisiae
Wodicka, L., Dong, H., Mittmann, M., Ho, M.-H., & Lockhart, D. J. (1997) · Nature Biotechnology · doi:10.1038/nbt1297-1359 · Cited by 973
Bhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1883 · Cited by 890
Self-citationWilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794 · cited 1×
“Although hepatocarcinoma-derived cell lines and immortalized hepatocytes can be reproducible and inexpensive, they display abnormal levels of liver-specific function”
BackgroundHewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Newton, D. J., Wang, R. W., & Lu, A. Y. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06500-6 · Cited by 605
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Cited by
Items 301–400 of 1,000
Hsieh, T. M., Benjamin Ng, C. W., Narayanan, K., Wan, A. C. A., & Ying, J. Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.06.029 · Cited by 77
“In the 2D monoculture controls, there was a significant drop in functionality of hepatocytes from Day 1 to Day 2, an observation that confirmed the findings of published literature [13,14].”
ResultBioprinting for Liver Transplantation
Kryou, C., Leva, C. V., Chatzipetrou, M., & Zergioti, I. (2019) · Bioengineering · doi:10.3390/bioengineering6040095 · Cited by 78
“M olayer culture, organoid culture and co-culture platforms have been established using culture plates [63], commercially available wells [64], dielectrophoresis micropatterning [65] and physical mask-based additive photopatterning methods [60].”
BackgroundMethodInfluentialCho, H., Kim, J., Park, H., Bang, J. W., Hyun, M. S., Bae, Y., Ha, L., Kim, D. Y., Kang, S. M., Park, T. J., et al. (2014) · Nature Communications · doi:10.1038/ncomms4137 · Cited by 76
Human Induced Pluripotent Stem Cells in Hepatology
Gerbal-Chaloin, S., Funakoshi, N., Caillaud, A., Gondeau, C., Champon, B., & Si-Tayeb, K. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.09.026 · Cited by 64
Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro
Kanabekova, P., Kadyrova, A., & Kulsharova, G. (2022) · Micromachines · doi:10.3390/mi13030428 · Cited by 70
Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells
Jun, Y., Kang, A. R., Lee, J. S., Park, S., Lee, D. Y., Moon, S., & Lee, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.045 · Cited by 75
Prot, J. M., Videau, O., Brochot, C., Legallais, C., Bénech, H., & Leclerc, É. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.054 · Cited by 75
Yasotharan, S., Pinto, S., Sled, J. G., Bolz, S.-S., & Günther, A. (2015) · Lab on a Chip · doi:10.1039/c5lc00021a · Cited by 62
Ramsden, D., Tweedie, D., Chan, T. S., Taub, M. E., & Li, Y. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.055897 · Cited by 74
In Vitro Immune Organs-on-Chip for Drug Development: A Review
Shanti, A., Teo, J., & Stefanini, C. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040278 · Cited by 65
“In a different application and in order to demonstrate the utility of such systems for drug screening, Khetani and Bhatia developed a microfluidic culture system for hepatocyte and hepatocyte-fibroblast coculture with patterned extracellular matrix and used it to quantify the acute and chronic toxicity of model hepato…”
BackgroundImmune Organs and Immune Cells on a Chip: An Overview of Biomedical Applications
Morsink, M., Willemen, N., Leijten, J., Bansal, R., & Shin, S. (2020) · Micromachines · doi:10.3390/mi11090849 · Cited by 73
“It would be ideal to study drug metabolism on a liver-on-a-chip device, specifically one which models the liver metabolism on a chip [86,87].”
BackgroundBioprinting technologies for disease modeling
Memic, A., Navaei, A., Mirani, B., Cordova, J. A. V., Aldhahri, M., Dolatshahi-Pirouz, A., Akbari, M., & Nikkhah, M. (2017) · Biotechnology Letters · doi:10.1007/s10529-017-2360-z · Cited by 73
Micro/nano-fabrication technologies for cell biology
Qian, T., & Wang, Y. (2010) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-010-0632-z · Cited by 73
“Micro/nano-technologies have also been applied in the clinic studies [43, 47], medical assays [2, 8], tissue engineering [1, 18, 24, 26], and drug development [29].”
Zhang, J., Wu, J., Li, H., Chen, Q., & Lin, J. (2015) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.01.013 · Cited by 73
“…of two-dimensional hepatic tissues that stably persisted for more than 200 d. Khetani and Bhatia first developed a miniaturized multiwell co-culture system for human liver cells with optimized microscale architecture that maintained phenotypic functions for several weeks(Khetani and Bhatia, 2008).”
BackgroundKobayashi, J., & Okano, T. (2010) · Science and Technology of Advanced Materials · doi:10.1088/1468-6996/11/1/014111 · Cited by 73
Retina-on-a-chip: a microfluidic platform for point access signaling studies
Dodson, K. H., Echevarria, F. D., Li, D., Sappington, R. M., & Edd, J. F. (2015) · Biomedical Microdevices · doi:10.1007/s10544-015-0019-x · Cited by 71
“To study the interactions between different cell types, a number of microfluidic cell co-culture platforms were developed to enable the study of controlled cell-cell interactions (Gao et al. 2011; Khetani and Bhatia 2008).”
BackgroundLi, F., Cao, L., Parikh, S., & Zuo, R. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.02.021 · Cited by 72
Yagi, H., Parekkadan, B., Suganuma, K., Soto–Gutiérrez, A., Tompkins, R. G., Tilles, A. W., & Yarmush, M. L. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0681 · Cited by 72
Alginate core-shell beads for simplified three-dimensional tumor spheroid culture and drug screening
Yu, L., Ni, C., Grist, S. M., Bayly, C. L., & Cheung, K. C. (2015) · Biomedical Microdevices · doi:10.1007/s10544-014-9918-5 · Cited by 72
“D cultures because they can offer good control over the size and characteristics of the cultures (Khetani and Bhatia 2008; Liu Tsang and Bhatia 2004).”
BackgroundOkochi, M., Takano, S., 伊佐治弥生, Senga, T., Hamaguchi, M., & Honda, H. (2009) · Lab on a Chip · doi:10.1039/b909304d · Cited by 72
Scaffold Free Bio-orthogonal Assembly of 3-Dimensional Cardiac Tissue via Cell Surface Engineering
Rogozhnikov, D., O’Brien, P. J., Elahipanah, S., & Yousaf, M. N. (2016) · Scientific Reports · doi:10.1038/srep39806 · Cited by 67
Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages
Chua, A. C. Y., Ong, J. J. Y., Malleret, B., Suwanarusk, R., Kosaisavee, V., Zeeman, A., Cooper, C. A., Tan, K. S. W., Zhang, R., Tan, B. H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11332-4 · Cited by 72
Kurokawa, Y. K., & George, S. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.07.004 · Cited by 59
Development of a microfluidic device for the maintenance and interrogation of viable tissue biopsies
Hattersley, S. M., Dyer, C. E., Greenman, J., & Haswell, S. J. (2008) · Lab on a Chip · doi:10.1039/b809345h · Cited by 62
Yu, T., Guo, Z., Fan, H., Song, J., Liu, Y., Gao, Z., & Wang, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.8232 · Cited by 70
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
Segovia-Zafra, A., Di Zeo-Sánchez, D. E., López-Gómez, C., Pérez-Valdés, Z., García-Fuentes, E., Andrade, R. J., Lucena, M. I., & Villanueva-Paz, M. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.11.013 · Cited by 70
Long‐Term Stability of Primary Rat Hepatocytes in Micropatterned Cocultures
Ukairo, O., Kanchagar, C., Moore, A., Shi, J., Gaffney, J., Aoyama, S., Rose, K., Krzyzewski, S., McGeehan, J., Andersen, M. E., et al. (2013) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21469 · Cited by 61
“We and others have shown that 3T3 fibroblasts and other nonliver derived stroma can induce functions in both animal and human hepatocytes, suggesting possible conservation of mechanisms [9, 29, 30].”
BackgroundMethodSelf-citationMicrotechnology for Mimicking In Vivo Tissue Environment
Sung, J. H., & Shuler, M. L. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0491-2 · Cited by 70
Microengineered Bioartificial Liver Chip for Drug Toxicity Screening
Delalat, B., Cozzi, C., Ghaemi, S. R., Polito, G., Kriel, F. H., Michl, T. D., Harding, F. J., Priest, C., Barillaro, G., & Voelcker, N. H. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801825 · Cited by 70
Human induced pluripotent stem cell-derived hepatocytes for toxicology testing
Mann, D. A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.981523 · Cited by 69
“These efforts include: the identification of small molecules [22], heterologous cell co-culture systems [23], flow-based models [24], and enhanced matrices and 3D culture formats [25,26].”
BackgroundA vascularized model of the human liver mimics regenerative responses
Chhabra, A., Song, H.-H. G., Grzelak, K. A., Polacheck, W. J., Fleming, H. E., Chen, C. S., & Bhatia, S. N. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115867119 · Cited by 63
“For 2D studies, Heps were cultured along with 3T3-J2 murine fibroblasts in MPCC configurations, as previously described (29, 30, 44).”
BackgroundMethodSelf-citationMicrofluidic trends in drug screening and drug delivery
Feng, J., Neužil, J., Manz, A., Iliescu, C., & Neužil, P. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116821 · Cited by 70
Generating Nonlinear Concentration Gradients in Microfluidic Devices for Cell Studies
Selimović, Š., Sim, W. Y., Kim, S. B., Jang, Y. H., Lee, W. G., Khabiry, M., Bae, H., Jambovane, S., Hong, J. W., & Khademhosseini, A. (2011) · Analytical Chemistry · doi:10.1021/ac2001737 · Cited by 63
Three-dimensional spheroid-forming lab-on-a-chip using micro-rotational flow
Ota, H., Yamamoto, R., Deguchi, K., Tanaka, Y., Kazoe, Y., Sato, Y., & Miki, N. (2009) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2009.11.061 · Cited by 70
Entry and replication of recombinant hepatitis C viruses in cell culture
Vièyres, G., & Pietschmann, T. (2012) · Methods · doi:10.1016/j.ymeth.2012.09.005 · Cited by 69
Davidson, M. D., Kukla, D. A., & Khetani, S. R. (2017) · Integrative Biology · doi:10.1039/c7ib00027h · Cited by 66
Self-citationLee-Montiel, F. T., Laemmle, A., Charwat, V., Dumont, L., Lee, C. S., Huebsch, N., Okochi, H., Hancock, M. J., Siemons, B., Boggess, S. C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.667010 · Cited by 54
“More physiological medium-to-cell ratios can be achieved by using the small system volumes of microfluidic devices (Khetani and Bhatia, 2008; Dash et al., 2009), which preserves the efficacy of low-concentration autocrine and paracrine signals, including secreted molecules, growth factors, matrices, and hormones (Abhy…”
Peters, D. T., Henderson, C. A., Warren, C. R., Friesen, M., Xia, F., Becker, C. E., Musunuru, K., & Cowan, C. A. (2016) · Development · doi:10.1242/dev.132209 · Cited by 68
“Although micropatterned co-culture can extend the viability of PHHs ex vivo (Khetani and Bhatia, 2008), there is a substantial need for a renewable source of human hepatocytes for in vitro studies and the development of cell-based therapies.”
BackgroundA microphysiological system model of therapy for liver micrometastases
Clark, A. M., Wheeler, S., Taylor, D. P., Pillai, V. C., Young, C. L., Prantil‐Baun, R., Nguyen, T., Stolz, D. B., Borenstein, J. T., Lauffenburger, D. A., et al. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214532596 · Cited by 69
“A second initiator of an inflammatory or stressed milieu is tissue stiffness (29, 68).”
BackgroundIntegration of in silico and in vitro platforms for pharmacokinetic–pharmacodynamic modeling
Sung, J. H., Esch, M. B., & Shuler, M. L. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.496251 · Cited by 64
“Utilizing this technique, it was possible to seed hepatocytes and fibroblasts with a control over the size and the spacing of ‘cell islands’, and find optimal geometric parameters [74].”
MethodWater-Stable Metal–Organic Framework/Polymer Composites Compatible with Human Hepatocytes
Neufeld, M. J., Ware, B. R., Lutzke, A., Khetani, S. R., & Reynolds, M. M. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b05948 · Cited by 68
Self-citationCell Culture Models for Hepatitis E Virus
Fu, R., Decker, C. C., & Thi, V. L. D. (2019) · Viruses · doi:10.3390/v11070608 · Cited by 68
“Culturing primary hepatocytes in sandwich monolayers or in spherical liver organoids helps in maintaining their complex polarization, which can be further improved by co-culture with non-parenchymal cells [81,124].”
BackgroundYouhanna, S. C., Kemas, A. M., Preiss, L. C., Zhou, Y., Shen, J. X., Cakal, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, R. Z., Lind, J. U., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000238 · Cited by 67
A biologically inspired lung-on-a-chip device for the study of protein-induced lung inflammation
Punde, T. H., Wu, W., Lien, P.-C., Chang, Y., Kuo, P.-H., Chang, M. D., Lee, K., Huang, C., Kuo, H., Chan, Y.-F., et al. (2014) · Integrative Biology · doi:10.1039/c4ib00239c · Cited by 67
Human Pluripotent Stem Cells for Modelling Human Liver Diseases and Cell Therapy
Dianat, N., Steichen, C., Vallier, L., Weber, A., & Dubart-Kupperschmitt, A. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020006 · Cited by 59
“In vitro, hepatocyte viability and liver-specific function are stabilized for several weeks by coculture with other cell types, by culture with extracellular matrix components or by using 3D bioreactor [60].”
Low-Turnover Drug Molecules: A Current Challenge for Drug Metabolism Scientists
Hutzler, J. M., Ring, B. J., & Anderson, S. R. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.066431 · Cited by 67
“With this design, hepatocytes have been shown to maintain good morphology, viability, and liver-specific cytochrome P450 and phase II enzyme gene expression for up to 6 weeks (Khetani and Bhatia, 2008).”
MethodXie, B., Sun, D., Du, Y., Jia, J., Sun, S., Xu, J., Liu, Y., Xiang, C., Chen, S., Xie, H., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0196-x · Cited by 64
“We tested the dose and time-dependent chronic toxicities of troglitazone, a representative chronic hepatotoxin.(28) The non-lethal concentrations of troglitazone caused extensive cell death after prolonged 9 days of drug exposure, in line with previous studies on PHHs (Fig.”
ResultAdvances in Engineered Liver Models for Investigating Drug-Induced Liver Injury
Lin, C., & Khetani, S. R. (2016) · BioMed Research International · doi:10.1155/2016/1829148 · Cited by 66
“For instance, overlaying confluent hepatocyte monolayers with an ECM gel, such as Matrigel or collagen, can slow down the functional decline of hepatocytes [13]; however, within the first few days, hepatocyte functions in such ECM-overlay culture models still decline to levels that are <10% of those measured in freshl…”
BackgroundMethodInfluentialSelf-citationEnhancing stem cell survival in vivo for tissue repair
Hyun, J. S., Tran, M. C., Wong, V., Chung, M. T., Lo, D. D., Montoro, D. T., Wan, D. C., & Longaker, M. T. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.11.003 · Cited by 66
Physiological oxygen tension reduces hepatocyte dedifferentiation in in vitro culture
Guo, R., Xu, X., Lu, Y., & Xie, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-06433-3 · Cited by 66
Long-term hepatitis B infection in a scalable hepatic co-culture system
Winer, B. Y., Huang, T., Pludwinski, E., Heller, B. L., Wojcik, F., Lipkowitz, G., Parekh, A., Cho, C., Shrirao, A. B., Muir, T. W., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00200-8 · Cited by 66
Advances in Engineered Human Liver Platforms for Drug Metabolism Studies
Underhill, G. H., & Khetani, S. R. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.083295 · Cited by 60
“, 2016) DDIs including P450 induction and inhibition (Khetani and Bhatia, 2008; Lin et al., 2016; Kratochwil et al., 2018) Transporter, metabolism, and/or P450 induction interplay on drug disposition (Ramsden et al.”
BackgroundInfluentialSelf-citationBioreactor engineering of stem cell environments
Tandon, N. M., Marolt, D., Cimetta, E., & Vunjak‐Novakovic, G. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.03.007 · Cited by 66
“…of cardiomyocytes from human stem cells (Kattman et al. 2006; Zhang et al. 2009), and human liver constructs that retain species-specific drug responses such as induction of P450s, drug metabolism, druginduced hepatotoxicity and drug-drug interactions (Khetani and Bhatia 2008; Wang et al. 2010).”
BackgroundHypoxia promotes liver stage malaria infection in primary human hepatocytes in vitro
Ng, S., March, S., Galstian, A., Hanson, K., Carvalho, T., Mota, M. M., & Bhatia, S. N. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.013490 · Cited by 54
“…micropatterned co-cultures (MPCCs) of primary human hepatocytes (PHHs) and supporting stromal fibroblasts result in stable hepatocyte function, including albumin secretion, urea production and cytochrome P450 levels, for several weeks compared with hepatocytes alone (Khetani and Bhatia, 2008).”
BackgroundMethodInfluentialSelf-citationUse of intrinsic clearance for prediction of human hepatic clearance
Chao, P., Uss, A. S., & Cheng, K. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903405622 · Cited by 62
“Plated hepatocytes can be cultured for weeks, and metabolic activity can also be maintained using co-culture technology [28,29].”
BackgroundA Minimized Valveless Electromagnetic Micropump for Microfluidic Actuation on Organ Chips
Mi, S., Pu, H., Xia, S., & Sun, W. (2020) · Sensors and Actuators A: Physical · doi:10.1016/j.sna.2019.111704 · Cited by 64
Stem Cell-Derived Systems in Toxicology Assessment
Suter-Dick, L., Alves, P. M., Blaauboer, B. J., Bremm, K.-D., Brito, C., Coecke, S., Flick, B., Fowler, P., Hescheler, J., Ingelman-Sundberg, M., et al. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0540 · Cited by 56
“Other scaled down perfusion hepatocyte bioreactors have been developed based on micropatterning and microfluidic techniques [91], which impose a physiological oxygen gradient and recapitulate liver zonation, incorporating homoand heterotypic cell–cell interactions that can be maintained for up to 2 weeks [92].”
Laser Sintering Approaches for Bone Tissue Engineering
Dinoro, J., Paxton, N. C., Skewes, J., Yue, Z., Lewis, P., Thompson, R. G., Beirne, S., Woodruff, M. A., & Wallace, G. G. (2022) · Polymers · doi:10.3390/polym14122336 · Cited by 64
“Additionally, other issues arise due to donor site morbidity, increased risk of infection, haemorrhage, poor integration, nerve damage, and associated pain from multiple surgeries [14,15].”
BackgroundLiver-on-a-chip devices: the pros and cons of complexity
Dalsbecker, P., Adiels, C. B., & Goksör, M. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00346.2021 · Cited by 64
Kumar, D., Nadda, R., & Repaka, R. (2024) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-024-03062-7 · Cited by 64
Akiyama, H., Itô, A., Kawabe, Y., & Kamihira, M. (2009) · Biomedical Microdevices · doi:10.1007/s10544-009-9284-x · Cited by 64
“…have been applied not only to tissue engineering but also to cell biological studies including analysis of cell–cell interactions (Hui and Bhatia, 2007), measurement of mechanical stress generated within multicellular aggregates (Nelson et al., 2005) and drug screening (Khetani and Bhatia, 2008).”
BackgroundThinking Inside the Box: Keeping Tissue-Engineered Constructs In Vitro for Use as Preclinical Models
Gibbons, M. C., Foley, M. A., & Cardinal, K. O. (2012) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2012.0305 · Cited by 64
“118 Their sys-tem consisted of 24-well plates micropatterned with collagen and seeded with human hepatocytes, followed by subsequent addition of 3T3 fibroblasts.”
Okuyama, T., Yamazoe, H., Mochizuki, N., Khademhosseini, A., Suzuki, H. R., & Fukuda, J. (2010) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2010.05.013 · Cited by 64
“Thus, approaches 2 that spatially localize one or more cell types are currently being intensively investigated 3 (12, 13).”
Purpose-driven biomaterials research in liver-tissue engineering
Ananthanarayanan, A., Narmada, B. C., Mo, X., McMillian, M., & Yu, H. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.10.006 · Cited by 65
Bertlein, S., Hikimoto, D., Hochleitner, G., Hümmer, J., Jüngst, T., Matsusaki, M., Akashi, M., & Gröll, J. (2017) · Small · doi:10.1002/smll.201701521 · Cited by 64
Sun, P., Zhang, G., Su, X., Jin, C., Yu, B., Yu, X., Lv, Z., Ma, H., Zhang, M., Wei, W., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.128 · Cited by 63
Active micromixer using electrokinetic effects in the micro/nanochannel junction
Yu, S., Jeon, T., & Kim, S. M. (2012) · Chemical Engineering Journal · doi:10.1016/j.cej.2012.05.044 · Cited by 63
Large-scale fabrication of free-standing and sub-μm PDMS through-hole membranes
The, H. L., Tibbe, M. P., Loessberg-Zahl, J., do Carmo, M. P., van der Helm, M. W., Bomer, J. G., van den Berg, A., Leferink, A., Segerink, L. I., & Eijkel, J. C. T. (2018) · Nanoscale · doi:10.1039/c7nr09658e · Cited by 63
Organs on microfluidic chips: A mini review
Jiang, B., Zheng, W., Zhang, W., & Jiang, X. (2013) · Science China Chemistry · doi:10.1007/s11426-013-4971-0 · Cited by 62
Yadav, J., Hassani, M. E., Sodhi, J. K., Lauschke, V. M., Hartman, J. H., & Russell, L. E. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1922435 · Cited by 62
Zhou, M., Ma, H., Lin, H., & Qin, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.070 · Cited by 62
Multicomponent protein patterning of material surfaces
Ganesan, R., Kratz, K. L., & Lendlein, A. (2010) · Journal of Materials Chemistry · doi:10.1039/b926690a · Cited by 62
Nanotechnology meets 3D in vitro models: Tissue engineered tumors and cancer therapies
da Rocha, E. L., Porto, L. M., & Rambo, C. R. (2013) · Materials Science and Engineering C · doi:10.1016/j.msec.2013.09.019 · Cited by 61
Modeling organ-specific vasculature with organ-on-a-chip devices
Lin, D. S. Y., Guo, F., & Zhang, B. (2018) · Nanotechnology · doi:10.1088/1361-6528/aae7de · Cited by 61
Gröger, M., Rennert, K., Giszas, B., Weiß, E., Dinger, J., Funke, H., Kiehntopf, M., Peters, F. T., Lupp, A., Bauer, M., et al. (2016) · Scientific Reports · doi:10.1038/srep21868 · Cited by 60
Li, W., Li, P., Li, N., Du, Y., Lü, S., Elad, D., & Long, M. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00379.2019 · Cited by 53
Mathur, A., Loskill, P., Hong, S., Lee, J. Y., Marcus, S. G., Dumont, L., Conklin, B. R., Willenbring, H., Lee, L. P., & Healy, K. E. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt375 · Cited by 56
The Future of Toxicity Testing
Andersen, M. E., Al‐Zoughool, M., Croteau, M. C., Westphal, M., & Krewski, D. R. (2010) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2010.483933 · Cited by 60
“Khetani and Bhatia (2008) have a miniaturized, multiwall culture system for human liver cells with optimized microscale architecture that are functional for several weeks.”
BackgroundKuo, C.-T., Chiang, C.-L., Yun-Ju Huang, R., Lee, H., & Wo, A. M. (2012) · NPG Asia Materials · doi:10.1038/am.2012.50 · Cited by 55
Leite, S. B., Teixeira, A. P., Miranda, J. P., Tostões, R. M., Clemente, J. J., Sousa, M. F. Q., Carrondo, M. J. T., & Alves, P. M. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.02.002 · Cited by 60
T‐cadherin modulates hepatocyte functions in vitro
Khetani, S. R., Chen, A. A., Ranscht, B., & Bhatia, S. N. (2008) · The FASEB Journal · doi:10.1096/fj.07-105155 · Cited by 57
Self-citation3D Cultivation Techniques for Primary Human Hepatocytes
Bachmann, A., Moll, M., Gottwald, E., Nies, C., Zantl, R., Wagner, H., Burkhardt, B., Sánchez, J., Ladurner, R., Thasler, W., et al. (2015) · Microarrays · doi:10.3390/microarrays4010064 · Cited by 59
“Co-culture of hepatocytes with different cell types such as human adipose-derived stem cells [17,27], human umbilical vein endothelial cells [26], fibroblasts [19], and different non-parenchymal liver cells [8,16] maintain cell functionality of all cell types and the biotransformation capacity of hepatocytes.”
BackgroundLiver-on-chips for drug discovery and development
Mehta, V., Karnam, G., & Madgula, V. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101143 · Cited by 35
“Hence, sandwich cultures [16] and micropatterned models [17] have been developed.”
BackgroundShen, K., Luk, S. O., Hicks, D. F., Elman, J. S., Bohr, S., Iwamoto, Y., Murray, R. M., Peña, K. C., Wang, F., Şeker, E., et al. (2014) · Nature Communications · doi:10.1038/ncomms6662 · Cited by 60
A robust high-throughput sandwich cell-based drug screening platform
Zhang, S., Tong, W., Zheng, B., Susanto, T. A. K., Xia, L., Zhang, C., Ananthanarayanan, A., Tuo, X., Sakban, R. B., Jia, R., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.09.064 · Cited by 58
“Despite the advent of many in vitro liver models [2,3], adaptation of these models into industry-scale drug”
Ballard, T. E., Wang, S., Cox, L. M., Moen, M. A., Krzyzewski, S., Ukairo, O. T., & Obach, R. S. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.066688 · Cited by 58
“172 these include liverchip (Dash et al., 2009) and micropatterned coculture (MPCC) systems (Khetani and Bhatia, 2008; Wang et al., 2010; Chan et al., 2013).”
BackgroundCui, J., Wang, H., Shi, Q., Sun, T., Huang, Q., & Fukuda, T. (2019) · Molecules · doi:10.3390/molecules24091762 · Cited by 59
Mosedale, M., Eaddy, J. S., Trask, O. J., Holman, N. S., Wolf, K. K., LeCluyse, E., Ware, B. R., Khetani, S. R., Lu, J., Brock, W. J., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfx206 · Cited by 56
“…cocultures (MPCCs) of primary human hepatocytes and 3T3-J2 murine embryonic fibroblasts have good retention of hepatocyte functionality (Khetani and Bhatia, 2008) and have been used extensively for long-term studies of perturbed hepatocellular pathways in vitro (Davidson et al., 2015;…”
BackgroundSelf-citationHuang, H.-C., Chang, Y.-J., Chen, W.-C., Harn, H. I.-C., Tang, M.-J., & Wu, C.-C. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0605 · Cited by 55
Lagaye, S., Shen, H., Saunier, B., Nascimbeni, M., Gaston, J., Bourdoncle, P., Hannoun, L., Massault, P.-P., Vallet-Pichard, A., Mallet, V., et al. (2012) · Hepatology · doi:10.1002/hep.25738 · Cited by 44
“However, this secretion is lower than that for the model of micropatterned hepatocyte cocultures.(33) Interestingly, we observed some differences between the sizes of core protein in HCV-infected liver slices and the size of core protein in HCVcc-infected Huh7.”
BackgroundEngineering of an Hepatic Organoid to Develop Liver Assist Devices
Soto-Gutierrez, A., Navarro-Alvarez, N., Yagi, H., Nahmias, Y., Yarmush, M. L., & Kobayashi, N. (2010) · Cell Transplantation · doi:10.3727/096368910x508933 · Cited by 51
Ino, K., Okochi, M., & Honda, H. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22104 · Cited by 57
Maguire, T., Novik, E., Chao, P., Barminko, J., Nahmias, Y., Yarmush, M., & Cheng, K.-C. (2009) · Current Drug Metabolism · doi:10.2174/138920009790820093 · Cited by 48
“Along these lines there have been previous reports of microreactor systems that couple microfluidics with hepatocyte cultures, by various groups [39, 41, 42, 45, 51, 64].”
BackgroundMicrofluidic generation of Buddha beads-like microcarriers for cell culture
Wang, J., Zou, M., Sun, L., Cheng, Y., Shang, L., Fu, F., & Zhao, Y. (2017) · Science China Materials · doi:10.1007/s40843-017-9081-5 · Cited by 57
Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs
Sung, J. H. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1908996 · Cited by 59
Takahashi, H., Yoshida, A., Gao, B., Yamanaka, K., & Shimizu, T. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121649 · Cited by 57
Hardelauf, H., Sisnaiske, J., Taghipour-Anvari, A. A., Jacob, P., Drabiniok, E., Marggraf, U., Frimat, J., Hengstler, J. G., Neyer, A., van Thriel, C., et al. (2011) · Lab on a Chip · doi:10.1039/c1lc20257j · Cited by 57
Human Organs‐on‐Chips: A Review of the State‐of‐the‐Art, Current Prospects, and Future Challenges
Zarrintaj, P., Saeb, M. R., Stadler, F. J., Yazdi, M. K., Nasirinezhad, M., Mohebbi, S., Seidi, F., Ganjali, M. R., & Mozafari, M. (2021) · Advanced Biology · doi:10.1002/adbi.202000526 · Cited by 56
Hagenbuch, B., Stieger, B., & Locher, K. P. (2024) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100023 · Cited by 56
High-throughput immunoassay through in-channel microfluidic patterning
Zheng, C., Wang, J., Pang, Y., Wang, J., Li, W., Ge, Z., & Huang, Y. (2012) · Lab on a Chip · doi:10.1039/c2lc40145b · Cited by 56
Metadata
- Authors
- Khetani, S. R., & Bhatia, S. N.
- Affiliations
- Massachusetts Institute of Technology (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Bhatia, Sangeeta N
- Venue
- Nature Biotechnology
- Published
- 2007-11-18
- Volume
- 26
- Issue
- 1
- Pages
- 120-126
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2023296392
- Cited by
- 1,219
- References
- 41
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 36 · 2023: 49 · 2022: 64 · 2021: 56 · 2020: 68 · 2019: 73 · 2018: 81 · 2017: 86 · 2016: 93 · 2015: 77 · 2014: 76 · 2013: 90 · 2012: 75
- FWCI
- 38.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- human liver cells, liver-on-a-chip, hepatotoxicity, drug development, phase I and II metabolism, canalicular transport, hepatocyte secretion, gene expression profiling, tissue engineering, microtechnology
- MeSH terms
- Biological Assay, Cells, Cultured, Equipment Design, Humans, Miniaturization, Drug Design, Flow Injection Analysis, Cell Culture Techniques, Equipment Failure Analysis, Hepatocytes, Microfluidic Analytical Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.